IMPACT OF COADMINISTRATION WITHOUT OR WITH FOOD ON THE 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TAF

被引：0

作者：

Kao, Jia-Horng ^{[1
]}

Chuang, Wan-Long ^{[2
]}

Chen, Chi-Yi ^{[3
]}

Ahn, Sang Hoon ^{[4
]}

Fung, Scott K. ^{[5
]}

Elkhashab, Magdy ^{[6
]}

Hann, Hie-Won L. ^{[7
]}

Ravendhran, Natarajan ^{[8
]}

Nguyen, Tuan T. ^{[9
]}

Tan, Susanna ^{[10
]}

Flaherty, John F. ^{[10
]}

Gagger, Anuj ^{[10
]}

Gao, Bing ^{[10
]}

Brainard, Diana M. ^{[10
]}

Phan, Charles G. ^{[11
]}

Lim, Young-Suk ^{[12
]}

Ferret, Maria Asuncion Buti ^{[13
]}

Lampertico, Pietro ^{[14
]}

机构：

[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan

[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[3] Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan

[4] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea

[5] Univ Toronto, Toronto, ON, Canada

[6] Toronto Liver Ctr, Res, Toronto, ON, Canada

[7] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[8] Digest Dis Associates PA, Wyomissing, PA USA

[9] T Nguyen Res & Educ Inc, San Diego, CA USA

[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[11] Mem Hermann Sugar Land, Sugar Land, TX USA

[12] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea

[13] Hosp Univ Vall dHebron, Dept Internal Med, Liver Unit, Barcelona, Spain

[14] Fdn Irccs Ca Granda Osped Maggiore Policlin, CRC AM & A Migliavacca Ctr Liver Dis, Div Gastroenterol & Hepatol, Milan, Italy

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

795

引用

页码：484A / 484A

页数：1

共 50 条

[1] IMPACT OF PRIOR TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT DURATION ON TENOFOVIR ALAFENAMIDE (TAF) SAFETY PROFILE IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TDF TO TAF
Chan, Henry Lik Yuen
Lampertico, Pietro
Ahn, Sang Hoon
Fung, Scott K.
Bae, Ho S.
Ramji, Alnoor
Lee, June Sung
Shafran, Stephen David
Gordon, Stuart C.
Phan, Charles G.
Tan, Susanna
Flaherty, John F.
Gaggar, Anuj
Wu, George
Suri, Vithika
Lau, Daryl
Byun, Kwan Soo
Agarwal, Kosh
Lim, Young-Suk
Buti, Maria
HEPATOLOGY, 2019, 70 : 287A - 288A
[2] IMPACT OF PRIOR TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT DURATION ON TENOFOVIR ALAFENAMIDE (TAF) SAFETY PROFILE IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TDF TO TAF
Chan, Henry Lik Yuen
Lampertico, Pietro
Ahn, Sang Hoon
Fung, Scott
Bae, Ho
Ramji, Alnoor
Lee, Jung Sung
Shafran, Stephen
Gordon, Stuart
Phan, Charles
Tan, Susanna
Flaherty, John
Gaggar, Anuj
Wu, George
Suri, Vithika
Lau, Daryl
Byun, Kwan Soo
Agarwal, Kosh
Lim, Young-Suk
Buti, Maria
GUT, 2020, 69 : A74 - A75
[3] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 96 WEEKS IN CHRONIC HBV (CHB) PATIENTS WITH RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE (TDF)
Chan, Henry Lik-Yuen
Buti, Maria
Flisiak, Robert
Ryder, Stephen
Streinu-Cercel, Adrian
Flaherty, John F.
Gaggar, Anuj
Mo, Shuyuan
Subramanian, G. Mani
Zoulim, Fabrian
Andreone, Pietro
Marcellin, Patrick
GUT, 2018, 67 : A97 - A97
[4] Efficacy and Safety of Tenofovir Alafenamide (TAF) at 96 Weeks in Chronic HBV (CHB) Patients with Risk Factors for Use of Tenofovir Disoproxil Fumarate (TDF)
Buti, Maria
Stepanova, Tatjana
Celen, Mustafa K.
Flisiak, Robert
Ryder, Stephen D.
Streinu-Cercel, Adrian
Gurel, Selim
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Mo, Shuyuan
Subramanian, Mani
Nurmukhametova, Elena
Zoulim, Fabien
Andreone, Pietro
Marcellin, Patrick
HEPATOLOGY, 2017, 66 : 488A - 488A
[5] 48-WEEK SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HBV ASIAN PATIENTS WITH TDF RISK FACTORS (RF)
Ahn, Sang Hoon
Kao, Jia-Horng
Hann, Hie-Won
Scott, Fung
Trinh, Huy
Nguyen, Tuan Trong
Paik, Seung Woon
Gaggar, Anuj
Flaherty, John
Yee, Leland
Jump, Belinda
Sethi, Shalini
Wu, George
Chan, Carol Yee Kwan
GUT, 2020, 69 : A73 - A74
[6] Long-term (96-week) efficacy and safety after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-infected, virologically suppressed adults
Raffi, Francois
Orkin, Chloe
Clarke, Amanda
Slama, Laurence
Gallant, Joel
Daar, Eric
Yan, Mingjin
Abram, Michael E.
Friborg, Sandra
Cheng, Andrew
Rhee, Martin
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[7] Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF) in Older, HIV-Infected Virologically-Suppressed Adults
Goldstein, D.
Ward, D.
Brinson, C.
Crofoot, G.
Ryu, J.
Haubrich, R.
Sparrow, T. L.
McCallister, S.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S48 - S48
[8] 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) SWITCH VS. CONTINUED TDF TREATMENT AMONG VIROLOGICALLY-SUPPRESSED HEPATITIS B PATIENTS OF ASIAN ETHNICITY
Ahn, Sang Hoon
Kao, Jia-Horng
Lampertico, Pietro
Ramji, Alnoor
Fung, Scott
Chuang, Wan-Long
Kim, Yoon Jun
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Lee, June Sung
Chan, Carol Yee Kwan
Yee, Leland J.
Sethi, Shalini
Flaherty, John
Zhao, Yang
Gaggar, Anuj
Hann, Hie Won
Lim, Young-Suk
Chan, Henry Lik Yuen
GUT, 2021, 70 : A77 - A78
[9] 1 YEAR SAFETY AND EFFICACY DATA IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TENOFOVIR DISOPROXIL FUMARATE (TDF) AFTER SWITCHING FROM TDF TO TENOFOVIR ALAFENAMIDE (TAF)
Pan, Calvin Q.
Gane, Edward
Seto, Wai-Kay
Janssen, Harry L.
Caruntu, Florin
Kim, Hyung Joon
Abdurakhmanov, Dzhamal
Nishiguchi, Shuhei
Bae, Ho
Mo, Shuyuan
Suri, Vithika
Gaggar, Anuj
Flaherty, John F.
Kao, Jia-Horng
Brunetto, Maurizia Rossana
Buti, Maria
GASTROENTEROLOGY, 2018, 154 (06) : S1132 - S1133
[10] SAFETY AND EFFICACY AT 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TDF USE
Buti, Maria
Lampertico, Pietro
Lim, Young-Suk
Agarwal, Kosh
Fung, Scott K.
Tsang, Owen
Elkhashab, Magdy
Kao, Jia-Horng
Luis Calleja, Jose
Khalili, Mandana
Ravendhran, Natarajan
Tan, Susanna
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Wu, George
Hann, Hie-Won L.
Pan, Calvin
Kim, Hyung Joon
Kennedy, Patrick T. F.
Chan, Henry Lik Yuen
HEPATOLOGY, 2019, 70 : 301A - 301A

← 1 2 3 4 5 →